Acetylcysteine (NAC) is the N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
Scope of the Report:
Europe is expected to be the largest market for NAC (Acetylcisteine) during the forecast period. The NAC (Acetylcisteine) market in this region is primarily driven by the growing demand for health products and drugs. Following Europe, North America is the second largest market with a market share of 26.61% in 2017.
The worldwide market for NAC (Acetylcisteine) is expected to grow at a CAGR of roughly 20.0% over the next five years, will reach 450 million US$ in 2024, from 180 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the NAC (Acetylcisteine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle ...
Table of Contents
1 Market Overview
1.1 NAC (Acetylcisteine) Introduction
1.2 Market Analysis by Type
1.2.2 Above 99%
1.3 Market Analysis by Applications
1.3.1 Nutritional Supplements
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
188.8.131.52 United States Market States and Outlook (2014-2024)
184.108.40.206 Canada Market States and Outlook (2014-2024)
220.127.116.11 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
18.104.22.168 Germany Market States and Outlook (2014-2024)
22.214.171.124 France Market States and Outlook (2014-2024)
126.96.36.199 UK Market States and Outlook (2014-2024)
188.8.131.52 Russia Market States and Outlook (2014-2024)
184.108.40.206 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China ...